Showing the single result

Emjard 10

250.00৳ Strip
  • Emjard, an SGLT-2 inhibitor, empowers glycemic control and reduces cardiovascular risks in adults with type 2 diabetes mellitus.
  • Its mechanism involves inhibiting renal glucose reabsorption, resulting in enhanced glucose excretion.
  • Administered once daily, Emjard offers convenience and efficacy in managing diabetes.
  • Caution is advised in patients with renal impairment, and regular monitoring ensures optimal therapeutic outcomes.